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Thromboembolic complications of hypertrophic cardiomyopathy (HCM) usuallyoccur in the setting of atrial fibrillation, left atrial, or left ventricular abnormali-ties.1-3 Thrombus formation in the left ventricular outflow tract (LVOT), however,whether spontaneous or in the postoperative setting, is thought to be exceedingly
uncommon, particularly in the absence of the aforementioned risk factors. Our report
describes the development of LVOT thrombus in a patient with obstructive HCM after septal
myectomy in association with postoperative embolic neurologic events.
Clinical Summary
A 58-year-old woman was referred to our institution for elective surgical myectomy for
symptomatic obstructive HCM. Several months before the operation, she reported increasing
dyspnea on exertion refractory to maximal medical therapy. Her history was significant for
idiopathic thrombocytopenic purpura, hypertension, hypothyroidism, and osteoarthritis. She
had also undergone several abdominal and gynecologic procedures with uncomplicated post-
operative courses. She denied a history of syncopal or presyncopal episodes, as well as any
history of atrial fibrillation, strokes, or transient ischemic attacks. Family history was signif-
icant for HCM and sudden cardiac death in several family members. 
A cardiac catheterization performed before the operation revealed normal coronary arter-
ies. An exercise stress echocardiogram showed normal resting left ventricular size and sys-
tolic function with an estimated ejection fraction of 60%, systolic anterior motion of the
mitral valve, and 3+ mitral regurgitation. There were no regional left ventricular wall motion
abnormalities, and the left atrial diameter was 3.9 cm. Peak dynamic gradient across the
LVOT was 88 mm Hg after provocation with exercise.
The patient underwent successful septal myectomy with an uncomplicated intraoperative
course. The myectomy specimen showed myocyte hypertrophy and disarray consistent with
HCM. An intraoperative transesophageal echocardiogram revealed no resting or provokable
gradient across the LVOT, 1+ mitral regurgitation, and no systolic anterior motion of the mitral
valve. Atrial fibrillation developed on the third postoperative day but within 24 hours was
pharmacologically converted to normal sinus rhythm. No further episodes of atrial fibrillation
occurred. On the seventh postoperative day, the patient had several discrete transient ischemic
attacks manifesting as visual field disturbances. Magnetic resonance imaging showed small
areas of acute ischemia in the right middle frontal gyrus and right occipital pole, raising the
suspicion of an embolic origin. Transesophageal echocardiography subsequently showed 2
nonmobile echo densities in the LVOT at the myectomy site suggestive of thrombi (Figure 1).
The left-sided heart valves and ascending aorta appeared normal, and no thrombus was
detected in the left atrium or atrial appendage. The patient was thus started on intravenous
unfractionated heparin because of her neurologic events and echocardiographic findings. To
further define the cardiac masses, a magnetic resonance imaging study was performed identi-
fying 2 pedunculated intracavitary masses in the LVOT consistent with thrombi, the largest of
which was 9 × 6 mm (Figure 2). Her clinical course stabilized without further evidence of
embolic events. Two days later, she became dyspneic and hypotensive. A repeated trans-
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esophageal echocardiogram showed no change in the intracavitary
masses; however, a large posterior loculated pericardial effusion
with associated tamponade was noted. The patient was taken to the
operating room where she underwent evacuation of the pericardial
effusion and removal of 4 masses along the LVOT, all attached to
the myectomy site. Pathologic examination was consistent with
thrombi. Oral anticoagulation therapy was initiated shortly after
reoperation and, on the 18th postoperative day, she was discharged
from the hospital in stable condition.
Discussion
Obstructive HCM is characterized by asymmetric hypertrophy of
the left ventricle with dynamic variable obstruction along the out-
flow tract. The cardiomyopathy has a prevalence estimated at
0.2% of the general population and is associated with devastating
manifestations such as sudden cardiac death and thromboembolic
events.2,4-6 The incidence of systemic thromboembolism in
patients with HCM is estimated at 3% to 7% per year.2,3
Thromboembolic events are usually in the setting of atrial fibrilla-
tion, which is present in about 15% of such patients.4-6 Other fac-
tors contributing to the increased risk of thromboembolism
include left ventricular systolic dysfunction and left atrial dilata-
tion, particularly when coupled with atrial fibrillation.
Because the occurrence of our reported finding in large pub-
lished surgical series is nearly nonexistent, this report suggests
that our patient may have had an underlying hypercoagulable
state. Although a complete thrombophilia evaluation was not per-
formed, the patient’s history of idiopathic thrombocytopenic pur-
pura may have been associated with a relative propensity for
thrombus formation. Arterial thromboses have been known to
occur in the setting of this condition, although the mechanism is
poorly understood.7 Additionally, evidence exists of activation of
the coagulation system in patients with HCM as shown in a study
by Yamamoto and associates.8 These investigators documented
increased levels of two specific markers of activation of the coag-
ulation system in patients with HCM. Furthermore, these markers
significantly correlated with left atrial size; our patient’s left
atrium, however, was only mildly dilated.
Figure 2. Small polypoid intracavitary lesions (arrowheads) attached to the endocardium of the outflow tract of the
left ventricle are seen on basal short-axis and 3-chamber long-axis images from dynamic “bright blood” (cine) mag-
netic resonance image-loops. Ao, Aorta; LA, left atrium; LV, left ventricle; RV, right ventricle.
Figure 1. Transesophageal echocardiography in the ~140° long-axis view showing an echo density at the myectomy
site suggestive of thrombus (arrow). AO, Aorta; LA, left atrium; LV, left ventricle; RV, right ventricle.
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In our patient, none of the traditional predisposing factors for
thromboembolism were present. Nevertheless, the thrombus for-
mation occurred in an unusual location, the myectomy site in the
LVOT, a location that is not mentioned in the reported literature.
The LVOT is an area of high-velocity, turbulent flow, which
should protect against thrombus formation. In large series of
patients undergoing surgical myectomy, thromboembolic events in
the postoperative period are uncommon, with the prevalence of
stroke being 0% to 1%.9-11 Brunner-La Schonbeck and col-
leagues,11 in their series of 110 patients undergoing surgical myec-
tomy, reported the maintenance use of warfarin in the
postoperative setting, up to 3 months, as prophylaxis against
thromboemboli stemming from the myectomy site. Other series
report the postoperative use of warfarin only in those with chronic
atrial fibrillation.9 The practice of routine postoperative anticoag-
ulation after surgical myectomy is controversial, with scarce data
on the true incidence of subclinical thrombus formation at the
myectomy site. With the relatively low early and late postoperative
stroke rates in postmyectomy patients, it is likely that the actual
occurrence is low. Although specific guidelines do not exist
regarding postoperative anticoagulation regimens, our current
practice has included low-dose daily aspirin in the early and late
postoperative period, unless a history of atrial fibrillation or prior
stroke coexists.
In conclusion, our report is the first, to our knowledge, to clearly
document postoperative thrombus formation at the myectomy site
in a patient with HCM. This potential source of thromboemboli
should be taken into account in the evaluation of postoperative
stroke in patients undergoing surgical septal myectomy. Until fur-
ther data exist, routine postoperative use of an antiplatelet agent
after surgical septal myectomy appears warranted.
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